ReVision Optics Closes $55 Million Financing
July 29, 2013ReVision Optics raised $55M with Canaan Partners, ProQuest Investments, InterWest Partners, Domain Associates, Johnson & Johnson Development Corporation and RusnanoMedInvest. RVO completed patient enrollment in US trial with Raindrop near vision inlay.
More »
Celator® Pharmaceuticals Appoints Michael R. Dougherty To Board Of Directors
July 24, 2013Mr. Dougherty was previously president and CEO of Adolor Corporation and has held senior leadership positions at Kalidex Pharmaceuticals, Genomics Collaborative, Genaera Corporation and Centocor. He is on the BOD at ViroPharma, Biota, Cempra and AltheRx.
More »
RightCare Solutions, Inc. Reports Positive Topline Results with D2S2 in Reducing All-Cause 30-day Readmissions from Pivotal Study
July 22, 2013The pivotal study examined the impact of D2S2 care transitions software platform on all-cause 30-day readmissions. The study met the primary endpoint showing 29% reduction in all-cause 30-day readmission rates in intervention group.
More »